CompoAtlas

Weider Creatine Monohydrate

Natural health product licensed in Canada

Other names
UPC: 57823 89356
Licence holder
Weider Nutrition Group, Canada
NPN or DIN-HM
80006131
Status
Inactive licence
Licence date
13 June 2008
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-(Aminoiminométhyl)-N-méthylglycine monohydraté750 mgNot calculated

Non-medicinal ingredients

Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified7 Capsule1 Tous les jours

Uses authorised in Canada

Helps athletes to improve their performance during brief, high intensity physical activity and enhances muscular development in combination with healthy regimen and resistance exercise.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80006131

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line